EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study
Status: | Terminated |
---|---|
Conditions: | Cancer, Cancer, Pancreatic Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - 90 |
Updated: | 4/27/2017 |
Start Date: | April 2014 |
End Date: | May 2016 |
EUS-guided Fine Needle Tissue Acquisition of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study
This research is being done to investigate if a new technique to biopsy the pancreas will
lead to a larger amount tissue material that can be analyzed. Investigators have called the
technique the "corkscrew" technique and believe it will allow obtaining a larger biopsy
sample during the endoscopic ultrasound examination. The corkscrew technique uses a
clockwise rotational movement to drive the needle into the pancreatic mass (like a wine
bottle opener twists and buries itself into a cork). It is believed that this will lead to a
better biopsy sample than the usual way and therefore result in a higher chance of a
diagnosis.
lead to a larger amount tissue material that can be analyzed. Investigators have called the
technique the "corkscrew" technique and believe it will allow obtaining a larger biopsy
sample during the endoscopic ultrasound examination. The corkscrew technique uses a
clockwise rotational movement to drive the needle into the pancreatic mass (like a wine
bottle opener twists and buries itself into a cork). It is believed that this will lead to a
better biopsy sample than the usual way and therefore result in a higher chance of a
diagnosis.
Inclusion Criteria:
- In-patients and out-patients between the age of 18 and 90 years with solid pancreatic
masses presenting for EUS-FNTA
Exclusion Criteria:
- Uncorrectable coagulopathy (INR > 1.5)
- Uncorrectable thrombocytopenia (platelet < 50,000)
- Uncooperative patients
- Pregnant women (women of childbearing age will undergo urine pregnancy testing, which
is routine for all endoscopic procedures)
- Refusal to consent form
- Prior negative FNTA
- In situ metallic biliary stents
- Predominantly cystic lesions
- Inaccessible lesions to EUS
We found this trial at
1
site
1800 Orleans St.
Baltimore, Maryland 21287
Baltimore, Maryland 21287
410-955-5000
Principal Investigator: Mouen A Khashab, MD
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
Click here to add this to my saved trials